Green Rush Science (GRS), Inc. is an Oregon based company whose mission is to pioneer the emerging clinical cannabis pharmaceutical industry via neuro-cannabinoid drug solutions and advancements in cannabis medical science.
We are currently in our privately held phase of shareholder offerings. If you would like to invest in Green Rush Science, please contact Paul Rosen, Director of Investor Relations, at investors@greenrushscience.com.
